| 发明名称 | Amorphous form of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereof | ||
| 摘要 | Disclosed is (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one monohydrochloride, forms, formulations, pharmaceutical compositions, processes of manufacturing and methods of use thereof. | ||
| 申请公布号 | US9290458(B2) | 申请公布日期 | 2016.03.22 |
| 申请号 | US201314401092 | 申请日期 | 2013.05.17 |
| 申请人 | GENENTECH, INC. | 发明人 | Chakravarty Paroma;Kothari Sanjeev;Gosselin Francis;Savage Scott J.;Stults Jeffrey |
| 分类号 | C07D239/70;A61K31/496;C07D403/04;A61K31/517 | 主分类号 | C07D239/70 |
| 代理机构 | Viksnins Harris & Padys PLLP | 代理人 | Viksnins Harris & Padys PLLP |
| 主权项 | 1. Amorphous (S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one monohydrochloride. | ||
| 地址 | South San Francisco CA US | ||